comparemela.com

Latest Breaking News On - சிஇஆர்டிஐஎஃப்ஐஇடி நிதி மேலாளர் - Page 1 : comparemela.com

Raymond James Financial, Inc (RJF) Stock Forecasts

Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer

Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer News provided by Share this article  Cumberland Pharmaceuticals Inc.  (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to   Director Finance & Accounting and Chief Financial Officer. In this role, he will manage all of Cumberland s finance and accounting activities while continuing to oversee corporate development and legal matters. John Hamm, Director Finance & Accounting and Chief Financial Officer for Cumberland Pharmaceuticals Hamm has more than 25 years of finance and accounting experience, including 20 years in health care. He previously served as Cumberland s Director Corporate Development, where he was responsible for business development, alliance management and legal activities.

Raymond James Financial, Inc (RJF) Stock Forecasts

Summary Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 4,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company s revenue is from the U.S. and 70% is from the company s wealth management segment. Subscribe to Yahoo Finance Plus Essential for full access Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next levelTry it Free ActionsDownload Full Report Michael WongSector Director Michael Wong, CFA, CPA, is director of equity research, financial services, North America, for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He is Chair of the Valuation committee. Before assuming his current role in 2017, he was a senior equity a

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.